Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share (BCAX)
CUSIP: 055477103
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 66,052,271
- Total 13F shares
- 36,408,664
- Share change
- +33,335,115
- Total reported value
- $927,393,381
- Price per share
- $25.47
- Number of holders
- 69
- Value change
- +$849,110,088
- Number of buys
- 67
Quarterly Holders Quick Answers
What is CUSIP 055477103?
CUSIP 055477103 identifies BCAX - Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2024
Recent filing periods for CUSIP 055477103:
Top shareholders of BCAX - Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Biocon Ltd |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,523,897
|
$73,155,178 | — | 16 Sep 2024 | |
| TPG GP A, LLC |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
1,960,425
|
$25,962,692 | — | 16 Sep 2024 | |
| James E. Flynn |
3/4/5
|
Possible Members of 10% Group, 10%+ Owner |
—
class O/S missing
|
1,795,174
|
$23,774,208 | — | 17 Sep 2024 | |
| FMR LLC |
3/4/5
|
Other* |
—
class O/S missing
|
1,115,333
|
$14,770,801 | — | 16 Sep 2024 | |
| FIL Ltd |
3/4/5
|
Other* |
—
class O/S missing
|
1,013,853
|
$13,426,861 | — | 16 Sep 2024 |
Institutional Holders of Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share (BCAX) as of Q3 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q4 2025 Across Filers
| Investor | Q4 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.